TruSight Oncology 500 - MII IG Kerndatensatz-Modul Molekulares Tumorboard v2027.0.0-ballot.1

MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

DeviceDefinition: TruSight Oncology 500

German

Profile: MII PR MTB Panel DeviceDefinition

MII EX MTB Panel Gene List
geneList: MII VS MTB Panel TSO 500 SNVs
scope: SNV-Detektion

MII EX MTB Panel Gene List
geneList: MII VS MTB Panel TSO 500 Fusions
scope: Fusions-Detektion

manufacturer: Illumina

DeviceNames

Name

Type

TruSight Oncology 500

User Friendly name

type: Genpanel

capability
type: SNV-Detektion

capability
type: Fusions-Detektion

capability
type: Signatur-Detektion

url: https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/DeviceDefinition/mii-dd-mtb-panel-tso-500

onlineInformation: https://www.illumina.com/products/by-type/clinical-research-products/trusight-oncology-500.html

note:

523 SNV-Gene, 55 Fusions-Gene; misst u. a. auch TMB/MSI.

IG © 2024+ Medizininformatik-Initiative. Package de.medizininformatikinitiative.kerndatensatz.mtb#2027.0.0-ballot.1 basiert auf FHIR 4.0.1. Erstellt 2026-09-15
Links: Inhaltsverzeichnis | QA-Bericht | netzwerk-universitaetsmedizin.de | medizininformatik-initiative.de | Impressum
HL7®, FHIR® and the FHIR flame design are registered trademarks of Health Level Seven International. Their use does not constitute endorsement by HL7.